Amicus Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Amicus Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
CONTACT:PRINCETON, N.J., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that Bradley Campbell, President and Chief Executive Officer, will present at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Monday, January 13, 2025, at 3:00 p.m. PT.
新澤西州普林斯頓，2025年1月2日（環球新聞稿）-- 愛美醫療（納斯達克：FOLD）今天宣佈，總裁兼首席執行官布萊德利·坎貝爾將於2025年1月13日（星期一）下午3:00在加州舊金山舉行的第43屆J.P.摩根醫療保健大會上進行演講。
A live audio webcast of the presentation can also be accessed via the investors section of the Amicus Therapeutics corporate website at .
該演講的現場直播音頻網絡也可以通過愛美醫療公司網站的投資者部分訪問。
About Amicus Therapeutics
Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a pipeline of cutting-edge, first- or best-in-class medicines for rare diseases. For more information please visit the company's website at , and follow on X and LinkedIn.
關於愛美醫療
愛美醫療（納斯達克：FOLD）是一家全球性、以患者爲中心的生物技術公司，專注於發現、開發和提供用於罕見疾病患者的高質量新藥物。憑藉卓越的患者關注度，愛美醫療致力於推動和擴展一系列前沿的首創或最佳藥物以治療罕見疾病。如需獲取更多信息，請訪問公司的官方網站，並在X和LinkedIn上關注我們。
CONTACT:
聯繫方式：
Investors:
Amicus Therapeutics
Andrew Faughnan
Vice President, Investor Relations
afaughnan@amicusrx.com
(609) 662-3809
投資者：
愛美醫療
安德魯·福根
副總裁，投資者關係
afaughnan@amicusrx.com
(609) 662-3809
Media:
Amicus Therapeutics
Diana Moore
Head of Global Corporate Affairs and Communications
dmoore@amicusrx.com
(609) 662-5079
媒體：
愛美醫療
戴安娜·摩爾
全球企業事務和通信負責人
dmoore@amicusrx.com
(609) 662-5079
FOLD–G
FOLD–G
